This report studies the Hirudin market. Hirudin is a naturally occurring peptide in the salivary glands of medicinal leeches (such as Hirudo medicinalis) that has a blood anticoagulant property. Hirudin is the most potent natural inhibitor of thrombin. Scope of the Report: This report focuses on the Hirudin in United States market, to split the market based on manufacturers, states, type and application. Market Segment by Manufacturers, this report covers The Medicines Company Keyken Minapharm Abbott SALUBRIS Pfizer, Inc Teva Pharmaceutical Industries Ltd DUOPUTAI Pentapharm Market Segment by States, covering California Texas New York Florida Illinois Market Segment by Type, covers Natural Hirudin Recombinant Hirudin Market Segment by Applications, can be divided into Thrombosis Disease Tumor Disease Others There are 17 Chapters to deeply display the United States Hirudin market. Chapter 1, to describe Hirudin Introduction, product type and application, market overview, market analysis by States, market opportunities, market risk, market driving force; Chapter 2, to analyze the manufacturers of Hirudin, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017; Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017; Chapter 4, to show the United States market by States, covering California, New York, Texas, Illinois and Florida, with sales, price, revenue and market share of Hirudin, for each state, from 2012 to 2017; Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017; Chapter 7, 8, 9, 10 and 11, to analyze the key States by Type and Application, covering California, New York, Texas, Illinois and Florida, with sales, revenue and market share by types and applications; Chapter 12, Hirudin market forecast, by States, type and application, with sales, price, revenue and growth rate forecast, from 2017 to 2022; Chapter 13, to analyze the manufacturing cost, key raw materials and manufacturing process etc. Chapter 14, to analyze the industrial chain, sourcing strategy and downstream end users (buyers); Chapter 15, to describe sales channel, distributors, traders, dealers etc. Chapter 16 and 17, to describe Hirudin Research Findings and Conclusion, Appendix, methodology and data source.
Table of Contents 1 Market Overview 1.1 Hirudin Introduction 1.2 Market Analysis by Type 1.2.1 Natural Hirudin 1.2.2 Recombinant Hirudin 1.3 Market Analysis by Applications 1.3.1 Thrombosis Disease 1.3.2 Tumor Disease 1.3.3 Others 1.4 Market Analysis by States 1.4.1 California Status and Prospect (2012-2022) 1.4.2
